Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Conditions

Untreated Adult Acute Lymphoblastic Leukemia | Untreated Childhood Acute Lymphoblastic Leukemia

What is the purpose of this trial?

This research study is developing a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.



Participation Guidelines

Age:
Up to 30 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Children's Oncology Group
National Cancer Institute (NCI)
Dates:
August 2010
Last Updated:
February 12, 2014
Study HIC#:
1008007227

Clinicaltrials.gov ID: NCT01142427